GlassScriptPhysician profile
Arvin Kumar Rao
NPI 1780635904
$19,327.87
in general payments reported to CMS, 2019-2025
57 companies · $3,277 in 2025
The $3,277 reported for 2025 was more than what 94% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,291 · 2020: $4,747 · 2021: $2,506 · 2022: $1,991 · 2023: $2,468 · 2024: $3,049 · 2025: $3,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,974 · Travel and Lodging: $2,821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,973.62 |
| Travel and Lodging | $2,820.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,001.18 | 2021-2025 | Quadcut, Propel, Stealthstation S8 Platform |
| Astrazeneca Pharmaceuticals LP | $2,700.99 | 2019-2025 | Fasenra, Breztri, Tezspire |
| Genentech USA, INC. | $1,850.95 | 2020-2022 | |
| Medtronic USA, INC. | $1,828.85 | 2020 | |
| Glaxosmithkline, LLC. | $1,720.01 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Aerin Medical INC. | $1,143.09 | 2019-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $741.50 | 2019-2022 | |
| Genzyme Corporation | $649.73 | 2019-2025 | |
| Optinose US, INC. | $486.02 | 2019-2024 | |
| Grifols USA, LLC | $362.14 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $337.33 | 2023-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $266.71 | 2021-2025 | Glassia, Hyqvia |
| Mylan Specialty L.P. | $199.12 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $197.05 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $191.10 | 2019-2025 | Zerbaxa, Winrevair, Recarbrio |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $178.88 | 2020-2023 | Entellus Medical Reinforced Anesthesia Needle |
| Amgen INC. | $157.47 | 2023-2025 | Tezspire, Lumakras |
| Alexion Pharmaceuticals, INC. | $149.75 | 2019-2023 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $149.51 | 2019-2023 | |
| Sunovion Pharmaceuticals INC. | $138.51 | 2019-2021 | |
| United Therapeutics Corporation | $134.40 | 2019-2021 | |
| Harmony Biosciences LLC | $126.45 | 2020-2025 | |
| Kaleo, INC. | $123.93 | 2021-2024 | Auvi-Q |
| Integra Lifesciences Corporation | $122.87 | 2019-2024 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Jazz Pharmaceuticals INC. | $86.19 | 2022-2025 | |
| Philips North America LLC | $86.16 | 2021-2023 | |
| Pfizer INC. | $80.68 | 2024-2025 | |
| Circassia INC. | $78.50 | 2019-2021 | |
| Intersect Ent, INC. | $77.02 | 2020-2022 | |
| Avadel Cns Pharmaceuticals, LLC | $70.12 | 2025 | Lumryz |
| Teva Pharmaceuticals USA, INC. | $67.04 | 2021-2023 | Airduo Digihaler |
| Insmed, INC. | $66.76 | 2019-2022 | |
| Axsome Therapeutics, INC. | $59.54 | 2023 | Sunosi |
| Pharming Healthcare, INC. | $49.65 | 2022-2023 | Ruconest |
| Caris Mpi, INC. | $49.46 | 2025 | Mi Cancer Seek |
| Shire North American Group INC | $49.20 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $47.19 | 2024 | Opsumit |
| Inspire Medical Systems, INC. | $46.46 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $42.73 | 2019-2021 | |
| Lucid Diagnostics INC. | $41.29 | 2022-2023 | |
| Portola Pharmaceuticals, LLC | $35.11 | 2019 | |
| Lilly USA, LLC | $34.92 | 2025 | Zepbound |
| Mallinckrodt Hospital Products INC. | $34.13 | 2020-2025 | Acthar |
| Biohaven Pharmaceutical Holding Company LTD. | $27.42 | 2022 | |
| Sanofi Pasteur INC. | $24.00 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $23.13 | 2025 | Neffy |
| Abbvie INC. | $21.83 | 2025 | |
| Advanced Respiratory, INC | $21.11 | 2019 | |
| 3b Medical, INC. | $20.07 | 2025 | Luna |
| Acclarent, INC | $20.00 | 2023 | Trudi Nav Cable |
| Idorsia Pharmaceuticals US INC | $17.76 | 2023 | Quviviq |
| Pulmonx Corporation | $17.75 | 2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Paratek Pharmaceuticals, INC. | $17.48 | 2023 | Nuzyra |
| Gilead Sciences, INC. | $17.16 | 2022 | |
| Baxter Healthcare | $17.11 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.88 | 2019 | |
| Mission Pharmacal Company | $11.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvin Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.